Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 59 Cholangiocarcinoma 19 Carcinoma, Renal Cell 16 Biliary Tract Neoplasms 11 Stomach Neoplasms 9 Thyroid Neoplasms 8 Endometrial Neoplasms 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Neoplasms 7 Melanoma 6 Uterine Cervical Neoplasms 5 Thyroid Carcinoma, Anaplastic 5 Neuroendocrine Tumors 5 Carcinoma, Non-Small-Cell Lung 5 Recurrence 4 Ovarian Neoplasms 4 Liver Neoplasms 4 Thyroid Cancer, Papillary 3 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Cirrhosis, Familial, with Pulmonary Hypertension 3 Brain Neoplasms 3 Advanced Biliary Tract Cancer 3 Adenocarcinoma, Follicular 3 Vulvar Neoplasms 2 Uveal Melanoma 2 Triple Negative Breast Neoplasms 2 Thymoma 2 Solid Tumors 2

Interventions

pembrolizumab 6 Mitotane 5 Cisplatin 5 cabozantinib 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 sodium thiosulfate 2 relacorilant 2 cixutumumab 2 cemiplimab 2 camrelizumab 2 apatinib 2 Radiotherapy 2 Nivolumab 2 Ipilimumab 2 Etoposide 2 Cytoreduction Surgical Procedures 2 milademetan 1 lenvatinib 1 gossypol acetic acid 1 dostarlimab 1 cabazitaxel 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vincristine 1 Tamoxifen 1 Suramin 1 Sunitinib 1 Sorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adrenocortical Carcinoma × lenvatinib × Clear all

NCT05036434 2026-01-23

ACCOMPLISH

National Cancer Center, Korea

Phase 2 Active not recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡